TAOK1 Antibody, FITC conjugated
CSB-PA752101LC01HU
ReactivityHuman
Product group Antibodies
TargetTAOK1
Overview
- SupplierCusabio
- Product NameTAOK1 Antibody, FITC conjugated
- Delivery Days Customer20
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateFITC
- Gene ID57551
- Target nameTAOK1
- Target descriptionTAO kinase 1
- Target synonymshKFC-B; hTAOK1; KFC-B; kinase from chicken homolog B; MAP3K16; MARK Kinase; MARKK; microtubule affinity regulating kinase kinase; prostate-derived STE20-like kinase 2; prostate-derived sterile 20-like kinase 2; PSK2; PSK-2; serine/threonine protein kinase TAO1 homolog; serine/threonine-protein kinase TAO1; STE20-like kinase PSK2; TAO1; thousand and one amino acid protein 1; thousand and one amino acid protein kinase 1
- HostRabbit
- IsotypeIgG
- Protein IDQ7L7X3
- Protein NameSerine/threonine-protein kinase TAO1
- Scientific DescriptionSerine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating \Thr-208\ of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade.
- ReactivityHuman
- Storage Instruction-20°C or -80°C
- UNSPSC12352203